Acromegaly: Patient And Physician Perspectives
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 152
- 试验地点
- 1
- 主要终点
- Assess patients with acromegaly health-related quality of life.
研究概览
简要总结
The purpose of the study is to assess the experiences of individuals with acromegaly who are receiving injections as part of their treatment regimen. Another objective of the study is to compare the patients' perception with their doctors' perceptions. The answers are important to help researchers and physicians understand what it is really like to take currently available treatments so that they can make efforts to improve patients' healthcare experiences, reduce treatment burden and, ultimately, improve patient's quality of life.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 94 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age >=18 years-old and <95 years-old
- •Patient self-reported acromegaly diagnosis which will be further confirmed by a knowledge screening based on current medications and doses
- •Currently on injectable Somatostatin analogues (SSA), Sandostatin® LAR or Somatuline® Depot, for >=12 months
- •Have not had a change in dosage of their acromegaly treatment at the time of or since their last office visit
- •Have seen their treating acromegaly physician within the past 12 +/-2 months NOTE: This timeframe allows two additional months for scheduling an appointment with their physician, since most patients should see their acromegaly physician at least once every 12 months
- •Ability to read and understand English
- •Live and receive acromegaly treatments in the US
- •Willing to provide signed informed consent
排除标准
- •Previous or current participant in Mycapssa® (octreotide capsules) trial
- •Use of Pegvisomant (Somavert®) monotherapy
- •Use of Pasireotide (Signifor®)
结局指标
主要结局
Assess patients with acromegaly health-related quality of life.
时间窗: The questionnaire should take no more than 60 minutes per subject.
The primary objective of this study is to assess the health-related quality of life for patients treated with SSA injections in the United States. Patients will be asked about their current quality of life and how acromegaly and acromegaly treatments may affect their quality of life from time of diagnosis to time of completing the survey.
Assess patient experiences with acromegaly treatments through patient questionnaires.
时间窗: The questionnaire should take no more than 60 minutes per subject.
The primary objective of this study is to assess the experience of patients treated with SSA injections in the United States. Patients will be asked about previous and current acromegaly treatments they have taken from the time of diagnosis to the current day they are completing the survey.
Assess patient satisfaction with acromegaly treatments.
时间窗: The questionnaire should take no more than 60 minutes per subject.
The primary objective of this study is to assess the treatment satisfaction of patients treated with SSA injections in the United States. Patients will be asked about previous and current acromegaly treatments they have taken from the time of diagnosis to the current day they are completing the survey.
次要结局
- Assess the concordance between patient's and physician's perceptions of acromegaly treatment satisfaction.(The questionnaire should take no more than 60 minutes per subject.)
- Assess the concordance between patient's and physician's perceptions of health-related quality of life.(The questionnaire should take no more than 60 minutes per subject.)
- Assess the concordance between patient's and physician's perceptions of acromegaly control (with/without biochemical lab results),(The questionnaire should take no more than 60 minutes per subject.)
研究者
Lizheng Shi
Principal Investigator
Tulane University